Indications covered in our China analysis:
Central Nervous System
Immunology & Inflammation
In key therapeutic areas impacting China, such as diabetes, a patient based forecast is produced, helping you to understand the market size and dynamics. Comparing treatment trends, segmented by city tiers you will be able to identify key growth drivers and the unmet need potential.
Examine patient populations and disease incidence and prevalence estimates over a 15 year period, segmented by China’s city tier system, along with an urban and rural split, helping you to recognize the market potential of China
Unravel the complexity of the Chinese healthcare system, gain insight into generics in China and key pricing, reimbursement, and regulatory developments to understand the key trends shaping the market, allowing you to respond quickly and effectively.
Get the latest China news, provided by our sister company SCRIP, helping you stay at the forefront of the pharma industry, reacting quickly and effectively to market developments.